Half-year report · HY
4885.TEDINET S100XFQT
Period2025-06-01 → 2025-11-30
Filed2026-01-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 50
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.7bn | 2025-06-01 → 2025-11-30 | Standalone | Net sales |
| Revenue | ¥6.7bn | 2024-06-01 → 2025-05-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.0bn | 2024-06-01 → 2024-11-30 | Standalone | Net sales |
| Operating income | ¥349m | 2025-06-01 → 2025-11-30 | Standalone | Operating income |
| Operating income | ¥154m | 2024-06-01 → 2024-11-30 | Standalone | Operating income |
| Ordinary income | ¥337m | 2025-06-01 → 2025-11-30 | Standalone | Ordinary income |
| Ordinary income | ¥430m | 2024-06-01 → 2025-05-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥171m | 2024-06-01 → 2024-11-30 | Standalone | Ordinary income |
| Profit before tax | ¥336m | 2025-06-01 → 2025-11-30 | Standalone | Income before income taxes |
| Profit before tax | ¥171m | 2024-06-01 → 2024-11-30 | Standalone | Income before income taxes |
| Net income | ¥244m | 2025-06-01 → 2025-11-30 | Standalone | Profit loss |
| Net income | ¥241m | 2024-06-01 → 2025-05-31 | Standalone | Net income loss (5-year summary) |
| Net income | ¥121m | 2024-06-01 → 2024-11-30 | Standalone | Profit loss |
| Total assets | ¥6.5bn | at 2025-11-30 | Standalone | Assets |
| Total assets | ¥5.3bn | at 2025-05-31 | Standalone | Assets |
| Total assets | ¥5.5bn | at 2024-11-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.8bn | at 2025-11-30 | Standalone | Liabilities |
| Total liabilities | ¥2.8bn | at 2025-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.7bn | at 2025-11-30 | Standalone | Net assets |
| Net assets / equity | ¥2.5bn | at 2025-05-31 | Standalone | Net assets |
| Net assets / equity | ¥2.3bn | at 2024-11-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.9bn | at 2025-11-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2025-05-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.8bn | at 2025-11-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.0bn | at 2025-05-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2024-11-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2024-05-31v | Standalone | Cash and cash equivalents |
| Operating cash flow | ¥282m | 2025-06-01 → 2025-11-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥216m | 2024-06-01 → 2025-05-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥137m | 2024-06-01 → 2024-11-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥141m | 2025-06-01 → 2025-11-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥371m | 2024-06-01 → 2025-05-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥188m | 2024-06-01 → 2024-11-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥672m | 2025-06-01 → 2025-11-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥123m | 2024-06-01 → 2025-05-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥336m | 2024-06-01 → 2024-11-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥60.85 | 2025-06-01 → 2025-11-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.42 | 2024-06-01 → 2025-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.29 | 2024-06-01 → 2024-11-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥59.98 | 2025-06-01 → 2025-11-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥59.49 | 2024-06-01 → 2025-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥29.82 | 2024-06-01 → 2024-11-30 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥10 | 2025-06-01 → 2025-11-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥25 | 2024-06-01 → 2025-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Equity ratio | 41.0% | at 2025-11-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.6% | at 2025-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.2% | at 2024-11-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 4,095,500 | at 2025-11-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2025-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2024-11-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| Chemical Products Businessreportable segment | revenue | 2025-06-01 → 2025-11-30 | ¥1.3bn |
| Chemical Products Businessreportable segment | revenue external | 2025-06-01 → 2025-11-30 | ¥1.3bn |
| Chemical Products Businessreportable segment | segment profit | 2025-06-01 → 2025-11-30 | ¥58m |
| Healthy Food Businessreportable segment | revenue | 2025-06-01 → 2025-11-30 | ¥660m |
| Healthy Food Businessreportable segment | revenue external | 2025-06-01 → 2025-11-30 | ¥660m |
| Healthy Food Businessreportable segment | segment profit | 2025-06-01 → 2025-11-30 | ¥6m |
| Pharmaceutical Businessreportable segment | revenue | 2025-06-01 → 2025-11-30 | ¥1.8bn |
| Pharmaceutical Businessreportable segment | revenue external | 2025-06-01 → 2025-11-30 | ¥1.8bn |
| Pharmaceutical Businessreportable segment | segment profit | 2025-06-01 → 2025-11-30 | ¥285m |
| —segment total | revenue | 2025-06-01 → 2025-11-30 | ¥3.7bn |
| —segment total | revenue external | 2025-06-01 → 2025-11-30 | ¥3.7bn |
| —segment total | segment profit | 2025-06-01 → 2025-11-30 | ¥349m |
| Chemical Products Businessreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥1.1bn |
| Chemical Products Businessreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥1.1bn |
| Chemical Products Businessreportable segment | segment profit | 2024-06-01 → 2024-11-30 | −¥17m |
| Healthy Food Businessreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥523m |
| Healthy Food Businessreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥523m |
| Healthy Food Businessreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥5m |
| Pharmaceutical Businessreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥1.4bn |
| Pharmaceutical Businessreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥1.4bn |
| Pharmaceutical Businessreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥167m |
| —segment total | revenue | 2024-06-01 → 2024-11-30 | ¥3.0bn |
| —segment total | revenue external | 2024-06-01 → 2024-11-30 | ¥3.0bn |
| —segment total | segment profit | 2024-06-01 → 2024-11-30 | ¥154m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 490
| Item | Context | Value | Unit |
|---|---|---|---|
| Security code | FilingDateInstant | 48850 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)室町ケミカル株式会社 | |
| Filer name in english | FilingDateInstant | MUROMACHI CHEMICALS INC. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2025-06-01 | |
| Current period end date | FilingDateInstant | 2025-11-30 | |
| Type of current period | FilingDateInstant | HY | |
| Current fiscal year end date | FilingDateInstant | 2026-05-31 | |
| Previous fiscal year start date | FilingDateInstant | 2024-06-01 | |
| Comparative period end date | FilingDateInstant | 2024-11-30 | |
| Previous fiscal year end date | FilingDateInstant | 2025-05-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所スタンダード | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Text · Plus | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | InterimInstant_No1MajorShareholdersMember | Original text (Japanese)村山 哲朗 | |
| Address major shareholders | InterimInstant_No1MajorShareholdersMember | Original text (Japanese)長野県北佐久郡軽井沢町 | |
| Name major shareholders | InterimInstant_No2MajorShareholdersMember | Original text (Japanese)青木 淳一 | |
| Address major shareholders | InterimInstant_No2MajorShareholdersMember | Original text (Japanese)群馬県太田市 | |
| Name major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)室町ケミカルグループ従業員持株会 | |
| Address major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)福岡県大牟田市新勝立町1丁目38-5 | |
| Name major shareholders | InterimInstant_No4MajorShareholdersMember | Original text (Japanese)株式会社商工組合中央金庫 | |
| Address major shareholders | InterimInstant_No4MajorShareholdersMember | Original text (Japanese)東京都中央区八重洲2丁目10-17 | |
| Name major shareholders | InterimInstant_No5MajorShareholdersMember | Original text (Japanese)日邦産業株式会社 | |
| Address major shareholders | InterimInstant_No5MajorShareholdersMember | Original text (Japanese)愛知県名古屋市中区錦1丁目10番1号 | |
| Name major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)外池 榮一郎 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |